Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule
- 20 January 2013
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (3), 387-392
- https://doi.org/10.1200/jco.2012.43.6691
Abstract
Purpose Longitudinal algorithms incorporate change over time in biomarker levels to individualize screening decision rules. Compared with a single-threshold (ST) rule, smaller deviations from baseline biomarker levels are required to signal disease. We demonstrated improvement in ovarian cancer early detection by using a longitudinal algorithm to monitor annual CA125 levels. Patients and Methods We retrospectively evaluated serial preclinical serum CA125 values measured annually in 44 incident ovarian cancer cases identified from participants in the PLCO (Prostate Lung Colorectal and Ovarian) Cancer Screening Trial to determine how frequently and to what extent the parametric empirical Bayes (PEB) longitudinal screening algorithm identifies ovarian cancer earlier than an ST rule. Results The PEB algorithm detected ovarian cancer earlier than an ST rule in a substantial proportion of cases. At 99% specificity, which corresponded to the ST-rule CA125 cutoff ≥ 35 U/mL that was used in the PLCO trial, 20% of cases were identified earlier by using the PEB algorithm. Among these cases, the PEB signaled abnormal CA125 values, on average, 10 months earlier and at a CA125 concentration 42% lower (20 U/mL) than the ST-rule cutoff. The proportion of cases detected earlier by the PEB algorithm and the earliness of detection increased as the specificity of the screening rule was reduced. Conclusion The PEB longitudinal algorithm identifies ovarian cancer earlier and at lower biomarker concentrations than an ST screening algorithm adjusted to the same specificity. Longitudinal biomarker assessment by using the PEB algorithm may have application for screening other solid tumors in which biomarkers are available.Keywords
This publication has 19 references indexed in Scilit:
- Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian CancerJNCI Journal of the National Cancer Institute, 2011
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial SpecimensCancer Prevention Research, 2011
- A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian CancerCancer Prevention Research, 2011
- A pilot study on subject‐based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sportsClinical Endocrinology, 2011
- From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sportsForensic Science International, 2008
- A forensic approach to the interpretation of blood doping markersLaw, Probability and Risk, 2008
- Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian CancerJournal of Clinical Oncology, 2005
- A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarkerBiostatistics, 2003
- Latent Class Models for Joint Analysis of Longitudinal Biomarker and Event Process DataJournal of the American Statistical Association, 2002
- Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal MarkersJournal of the American Statistical Association, 2001